Halozyme Therapeutics competitorsClear all
Partner Therapeutics's top competitors include Verastem Oncology and Blueprint Medicines.
 Partner Therapeutics Partner Therapeutics is developing and commercializing cancer medicines and combination therapies. |  Verastem Oncology Verastem Oncology is a biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer. |  Blueprint Medicines Blueprint Medicines discovers and develops highly selective kinase inhibitors for patients with genomically defined cancers. | |
Founding Date | Founding Date 2017 | Founding Date 2010 | Founding Date 2011 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations Lexington, US HQ Boston, US Lynnwood, US | Locations Needham, US HQ Walsrode, DE | Locations Cambridge, US HQ Amsterdam, NL Lugano, CH Zug, CH Cambridge, US |
Employees | Employees 1791% increase | Employees 4864% decrease | Employees 38376% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 196.8 m | Valuation ($) 3.3 b |
Twitter followers | Twitter followers 144 | Twitter followers 2.5 k | Twitter followers 2.6 k |
Number of tweets (last 30 days) | Number of tweets (last 30 days) 5 | Number of tweets (last 30 days) 14 | Number of tweets (last 30 days) 15 |
Average likes per tweet (last 30 days) | Average likes per tweet (last 30 days) 3.8 | Average likes per tweet (last 30 days) 8.2 | Average likes per tweet (last 30 days) 3.9 |
Percentage of tweets with engagement (last 30 days) | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) 86.67% |
Alexa Website Rank | Alexa Website Rank 120997 | Alexa Website Rank N/A | Alexa Website Rank 182678 |
Employee Rating | Employee Rating 4.4 | Employee Rating 4.3 | Employee Rating N/A |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $88.5m (FY, 2020) | Revenue (est.) $793.7m (FY, 2020) |
Cost of goods | Cost of goods N/A | Cost of goods $33.7m (FY, 2020) | Cost of goods $425k (FY, 2020) |
Gross profit | Gross profit N/A | Gross profit $54.8m (FY, 2020) | Gross profit $793.3m (FY, 2020) |
Net income | Net income N/A | Net income ($67.7m) (FY, 2020) | Net income $313.9m (FY, 2020) |
Funding | |||
Total funding raised | Total funding raised $ 60m | Total funding raised $ 170m | Total funding raised $ 115m |
For sources of this data, please see the company profile
View company profiles
Verastem Oncology
HQ
Needham, US
Employees
48
Verastem Oncology is a biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer.
View companyBlueprint Medicines
HQ
Cambridge, US
Employees
383
Blueprint Medicines discovers and develops highly selective kinase inhibitors for patients with genomically defined cancers.
View company